Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Amortization of Deferred Charges (2019 - 2021)

Biodesix filings provide 3 years of Amortization of Deferred Charges readings, the most recent being $41000.0 for Q1 2021.

  • On a quarterly basis, Amortization of Deferred Charges rose 13.89% to $41000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $147000.0, a N/A change, with the full-year FY2020 number at $144000.0, changed 0.0% from a year prior.
  • Amortization of Deferred Charges hit $41000.0 in Q1 2021 for Biodesix, up from $35000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $41000.0 in Q1 2021 to a low of $35000.0 in Q4 2019.
  • Median Amortization of Deferred Charges over the past 3 years was $35500.0 (2019), compared with a mean of $36750.0.
  • Biggest five-year swings in Amortization of Deferred Charges: changed 0.0% in 2020 and later increased 13.89% in 2021.
  • Biodesix's Amortization of Deferred Charges stood at $35000.0 in 2019, then changed by 0.0% to $35000.0 in 2020, then increased by 17.14% to $41000.0 in 2021.
  • The last three reported values for Amortization of Deferred Charges were $41000.0 (Q1 2021), $35000.0 (Q4 2020), and $36000.0 (Q1 2020) per Business Quant data.